High caffeine levels associated with weight loss and type 2 diabetes risk: BMJ

Published Date: 17 Mar 2023

UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...

Read Full News

Latest News

Type 2 Diabetes in 2025: Year in Review

Type 2 Diabetes in 2025: Year in Review

Impacts of the Lancet Commission on Obesity Treatment, With Pooja Singhal, MD

Impacts of the Lancet Commission on Obesity Treatment, With Pooja Singhal, MD

Gestational Diabetes Linked to Reduced Lung Function in Children

Gestational Diabetes Linked to Reduced Lung Function in Children

GLP-1 RA Use Linked to 42% Hepatocellular Carcinoma Risk Reduction in T2DM

GLP-1 RA Use Linked to 42% Hepatocellular Carcinoma Risk Reduction in T2DM

Orforglipron Maintains Weight Loss in Patients Switching from Semaglutide or Tirzepatide

Orforglipron Maintains Weight Loss in Patients Switching from Semaglutide or Tirzepatide

5 Endocrinology Headlines You Missed in November 2025

5 Endocrinology Headlines You Missed in November 2025

Todays Updates

Phase 3 REVITALYZ Trial of Once-Nightly Sodium Oxybate in Idiopathic Hypersomnia Finishes Enrollment Marco Meglio

Avadel's REVITALYZ trial for Lumryz in idiopathic hypersomnia shows promise, potentially offering a new treatment option for this underserved condition.

NeurologyLive® Year in Review 2025: Conference Coverage Recap NeurologyLive® Staff

NeurologyLive® provided in-depth coverage of conferences in 2025, highlighting advancements in diagnostics, treatments, and multidisciplinary care across multiple neurological conditions.

Ophthalmology in 2025: Year in Review

Ophthalmology in 2025: Year in Review

Increases in Physician Attrition Rates Could Worsen Shortages

Increases in Physician Attrition Rates Could Worsen Shortages

Hormonal Disorders in 2025: Year in Review

Hormonal Disorders in 2025: Year in Review

Todays Updates

Phase 3 REVITALYZ Trial of Once-Nightly Sodium Oxybate in Idiopathic Hypersomnia Finishes Enrollment Marco Meglio

Avadel's REVITALYZ trial for Lumryz in idiopathic hypersomnia shows promise, potentially offering a new treatment option for this underserved condition.

NeurologyLive® Year in Review 2025: Conference Coverage Recap NeurologyLive® Staff

NeurologyLive® provided in-depth coverage of conferences in 2025, highlighting advancements in diagnostics, treatments, and multidisciplinary care across multiple neurological conditions.

Ophthalmology in 2025: Year in Review

Ophthalmology in 2025: Year in Review

Increases in Physician Attrition Rates Could Worsen Shortages

Increases in Physician Attrition Rates Could Worsen Shortages

Hormonal Disorders in 2025: Year in Review

Hormonal Disorders in 2025: Year in Review

Latest News

Type 2 Diabetes in 2025: Year in Review

Impacts of the Lancet Commission on Obesity Treatment, With Pooja Singhal, MD

Gestational Diabetes Linked to Reduced Lung Function in Children

GLP-1 RA Use Linked to 42% Hepatocellular Carcinoma Risk Reduction in T2DM

Orforglipron Maintains Weight Loss in Patients Switching from Semaglutide or Tirzepatide

5 Endocrinology Headlines You Missed in November 2025

News All Time

Study reveals how uterine contractions are regulated by stretch and pressure during childbirth

When labor begins, the uterus must coordinate rhythmic, well-timed contractions to deliver the baby safely. While hormones such as progesterone and oxytocin are key contributors to that process, scientists have long suspected ...

Can't take hormone therapy for menopause? There are other options

Shilpa Gajarawala struggled with hot flashes, night sweats, sleep problems and brain fog. But given her history of breast cancer, treating these menopausal symptoms with hormone therapy wasn't an option.

FDA lifts major warnings on hormone replacement therapy

The U.S. Food and Drug Administration (FDA) is eliminating the prominent "black box" warnings on many hormone replacement therapy (HRT) medications, signaling a major shift in how the treatment is viewed for menopausal women.

Revised clinical practice guideline for treatment of chronic hypoparathyroidism in adults released

The European Society of Endocrinology (ESE) has published a Revised Clinical Practice Guideline for the Treatment of Chronic Hypoparathyroidism in Adults in the European Journal of Endocrinology.

Circadian rhythm discovery may transform what time of day doctors induce labor

In a discovery that could shift labor and delivery practices around the world, researchers at Michigan State University have found that the effectiveness of oxytocin—a common medication used to induce or speed up labor—depends ...

Gut bacterium could be key to tackling obesity crisis

The internet, libraries and bookshops are full of plans and advice on how to lose weight, from fad diets to intense exercise routines. But there could be another route to keeping the pounds away, and that's with a gut bacterium ...

Vagus nerve's right branch plays a key role in digestive signaling

After years of work, cognition and neuroscience doctoral student Hailey Welch is—for the first time—the lead author of a study published in an academic journal, a paper appearing in Cell Reports, which examined the role ...

Could exercising while losing weight preserve your muscles and help keep them 'young'?

When we lose weight, we don't just lose body fat—we lose muscle, too.

New study identifies overlooked tool for menopause symptom relief

A new study from the Kinsey Institute at Indiana University, published in the journal Menopause, finds self-pleasure is a valuable care strategy for managing menopause symptoms, especially mood and sleep changes. Most women ...

Experimental drug protects mitochondria and prevents kidney injury in mice

Serious damage to short-term kidney function—known as acute kidney injury, or AKI—can be fatal and also increase the risk of irreversible chronic kidney disease. It can be triggered by stressors ranging from sepsis to ...

Blocking gene improves metabolic health in obese mice without weight loss

Weill Cornell Medicine investigators have identified an early step in a cellular process that leads to inflammation in fat cells and may result in type 2 diabetes in people with obesity.

Sleep-related disorders associated with hypertension in postmenopausal women

Postmenopausal women are especially vulnerable to hypertension, which is a major cardiovascular risk factor. Women transitioning through or past the menopause transition are also more likely to report sleep disturbances (shorter ...

Nutritional supplement could help with fat metabolism activation therapies

Dr. Ann Coulter of Pennington Biomedical Research Center recently presented research on a novel nutritional supplement that targets fat cells to stimulate weight loss at the Bio on the Bayou conference in New Orleans.

Early-life ketone signaling may shape long-term metabolic health

In a major advance in metabolic research, scientists from National Taiwan University have discovered that ketone bodies produced naturally during the lactation period are not merely an alternative fuel, but act as powerful ...

Lactulose and tai chi show promise preventing falls for cirrhosis patients

Lactulose and tai chi can prevent falls in patients with cirrhosis, according to results from the LiveSMART Trial. Michigan Medicine hepatologists reported the findings as a late breaking abstract at The Liver Meeting 2025 ...

The flexible brain: How circuit excitability and plasticity shift across the day

Our brains do not react in a fixed, mechanical way like electronic circuits. Even if we see the same scene every day on our commute to work, what we feel—and whether it leaves a lasting impression—depends on our internal ...

Recommended News For You

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

For older patients with Hodgkin lymphoma, novel regimens produce high response rates.

Can Prior Authorization Be Better With Artificial Intelligence?

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

New protein target discovered for childhood medulloblastomas

Recommended Articles For You

Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates 

Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs 

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization 

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Reversing the toxic relationship with high doses of chemotherapy in oncology.

2.

Study finds 81% of cancer cures touted by TikTok videos are fake

3.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

4.

Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.

5.

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.

1.

Unpacking the Importance of White Blood Cells (WBCs) in the Body 

2.

Uncovering the Mystery of the Sessile Serrated Adenoma

3.

Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management

4.

Precision Medicine and Genomics: Harnessing Longitudinal Data Modeling to Decode Cancer Progression

5.

Revolutionizing Cancer Treatment: ESMO's Updated Recommendations for Tumour NGS

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

5.

Updates on Standard V/S High Risk Myeloma Treatment


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot